{"cluster": 16, "subcluster": 2, "abstract_summ": " Coronavirus disease 2019 (COVID-19) pandemic is caused by a newly emerged coronavirus (CoV) called SARS-CoV-2 . Patients with cardiovascular disease (CVD) comorbidities have significantly increased morbidity and mortality . Some health care providers and media sources have questioned the continued use of ACE inhibitors and ARBs . We propose that the application of RAAS inhibitors for COV-19 patients with CVDs may be beneficial rather than harmful ."}